Update in latest cancer research.
Cancer is a deadly disease that affects millions of people around the world, including Nepal. With new advancements in cancer research and treatment, there is now hope for those battling this disease. However all new research may not be directly applicable to our patients and the benifit are marginal in some cases.
KCC Meaningful Cancer Update 2023 is a program organized by the Kathmandu Cancer Center’s Research wing with aims of updating practicing oncologists in Nepal about latest in cancer research that can have a direct impact in day to day oncology practice.
The program will focus on ten recent practice-changing papers that have real-world impact. The research papers cover different aspects of cancer care, including diagnosis, treatment, and palliative care and most importantly they are relevant to Nepal’s context.
– Dr. Simit Sapkota
The program is expected to have real-world impact, as the research papers presented are practice-changing. This means that the information presented can be used by healthcare professionals to improve cancer care in Nepal. This is especially important given the increasing incidence of cancer in Nepal and the limited resources available for cancer care.
The program coordinators for the event are Dr. Anjani Kumar Jha, Dr. Subhas Pandit, and Dr. Simit Sapkota. They have selected broad range of topics which are common problems faced by clinical oncologist in day to day practice and needs to be addressed in scientific way.
The KCC Meaningful Cancer Update 2023 is an excellent opportunity for anyone interested in cancer care and research to learn about the latest advancements in the field. By attending the event, participants will learn about the latest research on cancer care, including the diagnosis and treatment of various types of cancer.
| Topic | Snippet | Speaker |
| Neutropenic Diet and Oncology Patients | Can patients eat whatever they want during chemotherapy? | Dr. Deepa Gautam |
| Comparing Olanzapine and Aprepitant as Antiemetics | Why use expensive drugs when you can use Olanzapine? | Dr. Abish Adhikari |
| Gefitinib vs. Gefitinib Plus Chemotherapy in EGFR-Mutated Lung Cancer | Will adding chemotherapy enhance the effectiveness of Gefitinib? | Dr. Arun Shahi |
| Low-Dose Nivolumab in Advanced Cancer | A new approach to immunotherapy, minimizing cost without compromising efficacy. | Dr. Pankaj Burman |
| Docetaxel as Radiosensitizer in Head and Neck Cancer | A new sidekick for our superhero cisplatin in head and neck chemo-radiation. | Dr. Deependra Shrestha |
| Organ Preservation in Rectal Adenocarcinoma | Can we finally say “goodbye” to our colostomy bags? | Dr. Saugat Poudel |
| Neoadjuvant Chemoradiotherapy vs. Upfront Surgery in Pancreatic Cancer | Is it time to say “wait” before Whipple’s? | Dr. Birendra Yadav |
| Low-Dose Radiation Therapy in Osteoarthritis | Interesting findings in using radiation therapy for osteoarthritis | Dr. Ranjana Karmacharya |
| Palliative Radiotherapy for Symptomatic Hepatocellular Carcinoma and Liver Metastases | Shining light around dark clouds. | Dr. Roshani Shrestha |
| Locoregional Radio-chemotherapy therapy vs. Chemotherapy Alone in Metastatic Nasopharyngeal Carcinoma | Cutting the metastatic cancer’s ego with a radical approach. | Dr. Sweta Baral |
The chairpersons for the upcoming event are renowned oncologists of Nepal; Dr. Gisup Nikha Prasiko, Dr. Rajendra Prasad Baral Dr. Bibek Acharya and Dr. Sudip Shrestha. With their combined expertise, the event promises to be a highly informative and engaging experience for all attendees. The 15-minute presentations followed by 5 minutes of discussion will ensure that each speaker has ample time to share insights on respective topic , while also allowing for meaningful dialogue and exchange of ideas.
The most exciting aspect is that the participants and presenters/ speakers can earn a Continuing Medical Education (CME) credits of 3 upon completion of the conference. Moreover, the program is planned for just a half day long with a total of four hours in order to fit into the attendee’s busy schedule. This research-oriented program promises that every attendees will leave the conference with greater insights and understanding of the quick practicality of ten potential research papers in cancer care.
